Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Becton Dickinson and Company (BDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 64,939,896
  • Shares Outstanding, K 268,258
  • Annual Sales, $ 15,983 M
  • Annual Income, $ 311,000 K
  • 36-Month Beta 1.21
  • Price/Sales 3.96
  • Price/Cash Flow 12.95
  • Price/Book 3.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 2.54
  • Number of Estimates 3
  • High Estimate 2.55
  • Low Estimate 2.52
  • Prior Year 2.48
  • Growth Rate Est. (year over year) +2.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
208.62 +14.65%
on 12/26/18
242.25 -1.26%
on 01/18/19
+24.93 (+11.64%)
since 12/21/18
3-Month
208.62 +14.65%
on 12/26/18
256.04 -6.58%
on 12/03/18
+3.85 (+1.64%)
since 10/22/18
52-Week
208.62 +14.65%
on 12/26/18
265.87 -10.03%
on 10/01/18
+2.48 (+1.05%)
since 01/22/18

Most Recent Stories

More News
Here's Why Investors Should Bet on Abiomed (ABMD) Stock Now

Strong contribution from Impella product line is likely to provide Abiomed (ABMD) a competitive edge in the MedTech space.

ABMD : 336.13 (+0.72%)
BDX : 239.19 (-1.19%)
VEEV : 103.11 (-2.75%)
OPK : 3.68 (-3.16%)
Edwards Life has the Best Relative Performance in the Health Care Equipment Industry (EW , BDX , BSX , MASI , BAX )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

EW : 168.29 (-0.07%)
BSX : 37.26 (-1.14%)
BDX : 239.19 (-1.19%)
BD Board Declares Dividends

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on March 29, 2019 to holders of record on March 8, 2019. The...

BDXA : 60.01 (-1.83%)
BDX : 239.19 (-1.19%)
Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Becton, Dickinson and Company, ArcBest, Tetra Tech and Nexstar Media

Zacks.com featured expert Kevin Matras highlights: Caseys General Stores, Becton, Dickinson and Company, ArcBest, Tetra Tech and Nexstar Media

TTEK : 52.56 (-1.76%)
BDX : 239.19 (-1.19%)
CASY : 132.59 (-1.07%)
ARCB : 38.36 (-2.59%)
NXST : 80.72 (-3.27%)
5 Cheap Dividend Stocks That Offer Growth

Amid heightened volatility and uncertainty, investors are looking for both income and growth in their portfolio. As a result, picking dividend growth stocks appear as a winning strategy.

TTEK : 52.56 (-1.76%)
BDX : 239.19 (-1.19%)
CASY : 132.59 (-1.07%)
ARCB : 38.36 (-2.59%)
NXST : 80.72 (-3.27%)
Here's Why Investors Should Hold AngioDynamics (ANGO) Now

AngioDynamics' (ANGO) flagship NanoKnife System is currently witnessing robust demand.

BDX : 239.19 (-1.19%)
VEEV : 103.11 (-2.75%)
PEN : 140.73 (-0.89%)
ANGO : 20.94 (+0.29%)
Cerner Picked by Remi Vista for Behavioral Health Technology

Apart from Cerner Integrated, Cerner's (CERN) revenue cycle solutions will help Remi Vista's financial operations.

CERN : 52.98 (-2.00%)
BDX : 239.19 (-1.19%)
VEEV : 103.11 (-2.75%)
OPK : 3.68 (-3.16%)
Here's Why Investors Should Retain athenahealth (ATHN) Stock

athenahealth (ATHN) gains from a broad product portfolio. However, it faces stiff competition in the MedTech space.

ATHN : 133.87 (+0.03%)
BDX : 239.19 (-1.19%)
VEEV : 103.11 (-2.75%)
OPK : 3.68 (-3.16%)
Allscripts Selected by Premier for Connected Health Platform

Premier Orthopaedics will leverage on Allscripts' (MDRX) Professional EHR, Practice Management software, FollowMyHealth and Payerpath suite of solutions.

MSFT : 105.68 (-1.88%)
BDX : 239.19 (-1.19%)
VEEV : 103.11 (-2.75%)
MDRX : 12.05 (-1.15%)
OPK : 3.68 (-3.16%)
BD Announces Preliminary Results For 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported preliminary financial results for the first fiscal quarter ended December 31, 2018. Subject...

BDX : 239.19 (-1.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade BDX with:

Business Summary

Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories....

See More

Key Turning Points

2nd Resistance Point 243.64
1st Resistance Point 241.42
Last Price 239.19
1st Support Level 237.26
2nd Support Level 235.32

See More

52-Week High 265.87
Fibonacci 61.8% 244.00
Last Price 239.19
Fibonacci 50% 237.24
Fibonacci 38.2% 230.49
52-Week Low 208.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar